Status:
COMPLETED
to Compare the Effectiveness of Thulium Fiber Laser and Holmium YAG Laser for Ureteroscopic Lithotripsy
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Ureteric Stone
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This prospective randomized clinical trial aimed to compare the difference in stone ablation rates of TFL and Ho:YAG laser in a clinical setting. Patients are randomized to receive URS with lithotrips...
Detailed Description
Having the advantages of being minimally invasive and simple, ureteroscopic lithotripsy is one of the treatment options for ureteric stone less than 1.5 cm. While many energy systems has been used for...
Eligibility Criteria
Inclusion
- Patients older than 18-years-old with informed consent
Exclusion
- Patients on anti-coagulation
- Patients with condition that increases the risk of urolithiasis (e.g. cystinuria, hyperparathyroidism, previous intestinal resection)
- Patients with abnormal urinary tract (e.g. ileal conduit, neobladder, ureteric stricture)
- Patients with stones \> 15 mm
Key Trial Info
Start Date :
May 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 30 2023
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT05218057
Start Date
May 1 2022
End Date
October 30 2023
Last Update
January 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
North District Hospital
Sheung Shui, Hong Kong